Overview Post Transplant Donor Lymphocyte Infusion Status: Terminated Trial end date: 2018-12-24 Target enrollment: Participant gender: Summary The purpose of this study is to test the hypothesis that a pre-infusion preparative regimen of cyclophosphamide and fludarabine will improve the effectiveness of DLI in patients with blood cancers. Phase: Phase 2 Details Lead Sponsor: Masonic Cancer Center, University of MinnesotaTreatments: CyclophosphamideFludarabine